Continuous Blood Glucose Monitoring Global Market 2024 – Latest Trends, Technological Advancement, Driving Factors And Forecast To 2033

Continuous Blood Glucose Monitoring Global Market
Spread the love

Overview and Scope
A continuous blood glucose monitoring device enables a person to better regulate glucose levels throughout the day and experience fewer low blood glucose situations.

Sizing and Forecast
The continous blood glucose monitoring market size has grown rapidly in recent years. It will grow from $8.09  billion in 2023 to $9.68  billion in 2024 at a compound annual growth rate (CAGR) of 19.7%.  The  growth in the historic period can be attributed to increase in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, rise in healthcare spending.

The continous blood glucose monitoring market size is expected to see exponential growth in the next few years. It will grow to $20.44  billion in 2028 at a compound annual growth rate (CAGR) of 20.5%.  The growth in the forecast period can be attributed to growing aging population, rising home healthcare, telehealth expansion, rise in healthcare expenditure, rise in disposable income. Major trends in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, partnerships and collaboration.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/continuous-blood-glucose-monitoring-global-market-report

Segmentation & Regional Insights

The continous blood glucose monitoring market covered in this report is segmented –

1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers

2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients

3) By End User: Hospitals, Homecare Diagnostics, Other End Users

Top Major Players
Roche
LifeScan Inc.
Medtronic
Abbott
GlySens Inc.

North America was the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continous blood glucose monitoring market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of diabetes is expected to propel the growth of the continuous blood glucose monitoring market going forward. Diabetes is a health disease that occurs when the blood glucose levels fluctuate in the body. Blood glucose monitoring devices can aid in the detection of trends and patterns that give a better full picture of a diabetic’s condition. For instance, in July 2021 the International Diabetes Federation (IDF), a Germany-based umbrella organization of over 240 national diabetes associations stated in its IDF Diabetes Atlas 10th edition that the estimated global population of individuals living with diabetes is expected to increase to 643 million by 2030 and further to 783 million by 2045, up from approximately 537 million adults aged 20 to 79 living with diabetes in the year 2021. Therefore, the increasing prevalence of diabetes is driving the continuous blood glucose monitoring market growth going forward.

Key Industry Players
Major companies operating in the continous blood glucose monitoring market include  F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.

The continous blood glucose monitoring  market report table of contents includes:
1. Executive Summary
2. Continuous Blood Glucose Monitoring Market Characteristics
3. Continuous Blood Glucose Monitoring Market Trends And Strategies
4. Continuous Blood Glucose Monitoring Market – Macro Economic Scenario
5. Global Continuous Blood Glucose Monitoring Market Size and Growth
………………………….
31. Global Continuous Blood Glucose Monitoring Market Competitive Benchmarking
32. Global Continuous Blood Glucose Monitoring Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market
34. Continuous Blood Glucose Monitoring Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →

Leave a Reply

Your email address will not be published. Required fields are marked *